PFM Health Sciences’s Dycom Industries DY Stock Holding History

PFM Health Sciences’s Portfolio DY Stock Details DY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-66,976	Closed	-$5.38M	–	105
2016 Q4	$5.38M	Buy	+66,976	New	+$5.42M	0.15%	87

Other funds holding DY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Homestead Advisers Arlington, Virginia $4.02B AUM 34.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Peconic Partners New York $8.04B AUM 107.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

PFM Health Sciences's DY Position: Q1 2017 in Review

PFM Health Sciences sold out of Dycom Industries (DY) in Q1 2017, closing a stake of 66,976 shares — an estimated $5.38M sold.

PFM Health Sciences first reported a position in DY in Q4 2016 and held it in 1 quarter. The position peaked at $5.38M in Q4 2016. 320 funds tracked by Wall St. Rank hold DY as of Q1 2017.

PFM Health Sciences reported no remaining Dycom Industries position as of Q1 2017 after selling out during the quarter.
PFM Health Sciences sold 66,976 Dycom Industries shares in Q1 2017, an estimated $5.38M.
PFM Health Sciences first reported a position in Dycom Industries in Q4 2016 and held it in 1 quarter.
PFM Health Sciences's Dycom Industries position peaked at $5.38M in Q4 2016.
320 funds tracked by Wall St. Rank held Dycom Industries as of Q1 2017.

Based on PFM Health Sciences's 13F filing for Q1 2017, filed 15 May 2017.